Sort
10,766 grants matching “checkpoint inhibitor”
Profiling and leveraging bystander T cells within the tumor microenvironment
$90,392Nicholas Joseph Maurice · University Of Minnesota · K00 · FY2023 · CA
Severe Acute Respiratory Failure After Immune Checkpoint Inhibitor Therapy: Risk Factors and Outcomes
$90,244Rupali Sood · Johns Hopkins University · F32 · FY2025 · HL
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
$90,030Evanthia Theodosiou Roussos Torres · University Of Southern California · P20 · FY2024 · CA
Immune Checkpoints for Intestinal Innate Lymphoid Cells
$90,000Jennifer Kaoru Bando · Washington University · K99 · FY2020 · DK
Tumor Intrinsic Regulation of Immune Evasion Pathways in Breast Cancer
$89,864Sheera Rosenbaum · University Of Colorado Denver · K00 · FY2022 · CA
Potential role of brachyury in HLA class I antigen processing machinery component downregulation in chordoma cells
$89,856Soldano Ferrone · Massachusetts General Hospital · R03 · FY2020 · CA
Nuclear Dynamics and Cancer Program
$89,688Johnathan R. Whetstine · Research Inst Of Fox Chase Can Ctr · P30 · FY2025 · CA
REGULATED PROTEOLYSIS AND LONG-TERM MEMORY
$89,677New York State Psychiatric Institute · R01 · FY2000 · MH
Advancing the commercialization readiness of nanoparticle-based immunotherapy for cancer treatment
$89,348Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · SB1 · FY2025 · CA
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$89,092Barbara Burtness · Yale University · P50 · FY2024 · DE
Repurposing Bruton's tyrosine kinase (BTK) inhibitors to reverse immunosuppression in high-grade serous ovarian cancer (HGSC)
$89,000Laurie H Glimcher · Dana-Farber Cancer Inst · R03 · FY2023 · CA
Repurposing Bruton's tyrosine kinase (BTK) inhibitors to reverse immunosuppression in high-grade serous ovarian cancer (HGSC)
$89,000Laurie H Glimcher · Dana-Farber Cancer Inst · R03 · FY2022 · CA
Uncovering actionable signaling pathways required for solid tumor brain metastasis
$88,956Jacob Peter Hoj · Duke University · K00 · FY2022 · CA
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$88,878Madhav V Dhodapkar · Emory University · U54 · FY2024 · CA
Investigating Immune Responses to Neoantigen Cancer Vaccines using In Vivo Functionalized Lineage
$88,695Camila Robles-Oteiza · Dana-Farber Cancer Inst · K00 · FY2023 · CA
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
$88,666Aritro Nath · Beckman Research Institute/City Of Hope · U01 · FY2024 · CA
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
$88,666Aritro Nath · Beckman Research Institute/City Of Hope · U01 · FY2024 · CA
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$87,961Barbara Burtness · Yale University · P50 · FY2024 · DE
DNA Damage and Immunogenicity in Ewing Sarcoma
$87,882Kelly Bailey · Mayo Clinic Rochester · K08 · FY2025 · CA
Molecular mechanisms of genome maintenance during DNA replication and repair
$87,832Kamakoti P. Bhat · Stanford University · K00 · FY2019 · CA
Identifying Genetic Drivers of the Immunosuppressive Tumor Microenvironment in Lung Cancer
$87,804Gurkan Mollaoglu · Icahn School Of Medicine At Mount Sinai · K00 · FY2019 · CA
Profiling and leveraging bystander T cells within the tumor microenvironment
$87,703Nicholas Joseph Maurice · University Of Minnesota · K00 · FY2022 · CA
Study of Anti-Survival signals in NF1
$87,540Changyan Chen · Northeastern University · R01 · FY2014 · CA
Precision vitamin D supplementation as a novel approach to prevent lung cancer progression
$87,350Pamela A Hershberger · Roswell Park Cancer Institute Corp · R03 · FY2021 · CA
Precision vitamin D supplementation as a novel approach to prevent lung cancer progression
$87,350Pamela A Hershberger · Roswell Park Cancer Institute Corp · R03 · FY2020 · CA